Nkarta, Inc. Sublease Income
Nkarta, Inc. (NKTX) reported Sublease Income of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2026-08-10
- Nkarta, Inc. sublease income for the quarter ending 2026-06-30 was $0.00.
- Nkarta, Inc. sublease income for the quarter ending 2026-03-31 was $0.00.
- Nkarta, Inc. sublease income for the quarter ending 2025-09-30 was $0.00.
- Nkarta, Inc. sublease income for the quarter ending 2025-06-30 was $0.00.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |